These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24152659)

  • 1. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
    Dong A; Zuo C; Lu J; Wang Y
    Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
    Dong A; Zuo C; Lu J; Wang Y
    Clin Nucl Med; 2014 Jul; 39(7):650-2. PubMed ID: 23877521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate.
    Dong A; Gong J; Wang Y; Zuo C
    Clin Nucl Med; 2014 Oct; 39(10):889-91. PubMed ID: 24217548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant nonepithelial prostate tumors: FDG PET/CT findings with MRI and CT correlation.
    Dong A; Zhang H; Wang Y; Gong J; Zuo C; Yang J; Lu J
    Clin Nucl Med; 2015 Jan; 40(1):14-20. PubMed ID: 24999682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
    Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
    Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings.
    Zhang WD; Li CX; Liu QY; Hu YY; Cao Y; Huang JH
    Eur J Radiol; 2011 Nov; 80(2):269-73. PubMed ID: 20650589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
    Hsieh TC; Lin CC; Kao CH; Wu YC; Sun SS
    Clin Nucl Med; 2016 Jan; 41(1):86-7. PubMed ID: 26402135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of the prostate lesions with increased FDG uptake on (18)F-FDG PET/CT.
    Dong A; Bai Y; Wang Y; Zuo C; Lu J
    Abdom Imaging; 2014 Aug; 39(4):908-21. PubMed ID: 24599406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI, enhanced CT, and FDG PET/CT in primary retroperitoneal mucinous cystadenocarcinoma.
    Dong A; Zhai Z; Wang Y; Zuo C
    Clin Nucl Med; 2015 Jan; 40(1):50-3. PubMed ID: 24445275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT.
    Liu Y; Xu B
    Clin Nucl Med; 2016 Mar; 41(3):224-6. PubMed ID: 26402134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer.
    Rosenkrantz AB; Koesters T; Vahle AK; Friedman K; Bartlett RM; Taneja SS; Ding YS; Logan J
    Clin Nucl Med; 2015 Apr; 40(4):e236-40. PubMed ID: 25608166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
    Sahiner I; Akkas BE; Ucmak Vural G
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
    Dong A; Zhang J; Wang Y; Zhai Z; Zuo C
    Clin Nucl Med; 2015 Feb; 40(2):134-7. PubMed ID: 24300356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
    Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
    Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.